Soligenix (SNGX) Stock Performance Update
- Current trading price: USD 0.35
- Day‑to‑day change: Down 2.86 % as of 11:07 AM Central European Time on Wednesday, 21 March 2026.
- 24‑hour volume: Approximately USD 23.7 k worth of shares were traded.
- Total shares outstanding: 21.8 million.
- Market capitalization: USD 7.7 million.
- Year‑to‑date change (since last month end): Down 8.11 %.
- 200‑day simple moving average: USD 0.73.
- 52‑week range: Highest price USD 1.70 (12 December 2025); lowest price USD 0.28 (5 December 2026).
Comparative Performance of Peer Stocks (Last 24 Hours)
| Stock | Symbol | 24‑hour change | Current price | Market capitalization |
|---|---|---|---|---|
| Barfresh Food | BRFH | +1.79 % | USD 0.64 | USD 9.1 million |
| Biovie | BIVI | +14.17 % | USD 1.24 | USD 9.1 million |
| Multisensor Ai | MSAI | +2.46 % | USD 4.27 | USD 9.2 million |
| Aterian | ATER | –1.25 % | USD 0.58 | USD 9.2 million |
| Adial | ADIL | +3.72 % | USD 3.82 | USD 9.2 million |
Company Overview
Soligenix, Inc. is a biotechnology firm headquartered in Princeton, United States. The company focuses on developing therapeutics and vaccines for gastrointestinal graft‑versus‑host disease, cancer, and both military and civilian immunization programs. Soligenix is listed on the Nasdaq stock exchange and launched its initial public offering on 15 June 1987. Further information is available on the company’s website at www.soligenix.com .
